-
Cost-Effectiveness of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in HER2-Positive Early Breast Cancer in China: A Post-Hoc Analysis of the FeDeriCa Trial
Mar 10, 2025, 14:00 PM -
Advancing the Development of Real-World Data for Cancer Care in China: Challenges and Opportunities
Mar 10, 2025, 14:00 PM -
Evidence for the Cumulative Impact of Social Determinants of Health (SDOH) on Cancer Mortality: A Scoping Review
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel as a Second-Line Treatment for Diffuse Large B-Cell Lymphoma in China
Mar 10, 2025, 14:00 PM -
Analysis of Real-World Evidence Use Across FDA Submissions in 2022 and 2023
Mar 10, 2025, 14:00 PM -
Healthcare Burden Among Patients with Graves Disease: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Inclusion of Caregiver Costs and Quality of Life in Cost Effectiveness Analyses of Treatments for Neurological Conditions: Review of HTA Guidance Documents and Appraisals
Mar 10, 2025, 14:00 PM -
Patient Characteristics Associated with the Use of Newly Approved Disease-Modifying Therapy (DMT) for Sickle Cell Disease in Texas Medicaid
Mar 10, 2025, 14:00 PM -
Race and Ethnicity Differences in the HPV Vaccine Initiation Prompted by Electronic Reminders
Mar 10, 2025, 14:00 PM -
Modelling Methods for Economic Evaluations of Non-Statin Lipid Lowering Therapies for Reducing Cardiovascular Risk: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Application of Sentiment Analysis to Aid in Evaluation of Patient Reported Outcome Measures: Analysis of Qualitative Cognitive Debriefing Interviews
Mar 10, 2025, 14:00 PM -
Cost Savings with Treosulfan and Fludarabine Conditioning Regimen vs. RIC (Bu2/Flu and Flu/Mel) and MAC Regimens (Bu4/Flu and Bu4/Cy) in Patients Undergoing Allogeneic HSCT for AML or MDS
Mar 10, 2025, 14:00 PM -
Role of Generative Artificial Intelligence in Assisting Systematic Review Process in Health Research: A Systematic Review
Mar 10, 2025, 14:00 PM -
Exploring the Potential Health Economic Value of the Aldosterone Synthase inhibitor and Sodium Glucose Transporter 2 inhibitor Combination in Chronic Kidney Disease
Mar 10, 2025, 14:00 PM -
Knowledge and Willingness to Self-Sampling About Cervical Cancer Screening in Zala County, Hungary
Mar 10, 2025, 14:00 PM -
The Utility of Adaptive Design Clinical Trials for Vaccines
Mar 10, 2025, 14:00 PM -
Dupilumab Improves Health-Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation: Results From the BOREAS and NOTUS Trials
Mar 10, 2025, 14:00 PM -
Racial and Health Insurance Status Disparities in the Use of Percutaneous Vertebral Augmentation and Healthcare Utilization for Osteoporotic Vertebral Fractures: A Retrospective Observational Analysis
Mar 10, 2025, 14:00 PM -
Study on Online Tools of Pharmacoeconomic Model Construction and Value Communication
Mar 10, 2025, 14:00 PM -
Perfect Health Reporting on EQ-5D-5L: The Role of Personal, Family and Social Network Illness Experiences
Mar 10, 2025, 14:00 PM